ACell hunts for manufacturing site

ACell is considering opening a new manufacturing plant in Winston Salem, NC, that could employ as many as 100 people. However, the company would need to scare up $15 million to $30 million to fund the expansions, and it's not clear yet whether it will be able to secure that level of financing. ACell is developing technology that could speed wound healing and regenerate tissue. Article

Suggested Articles

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.

After culling a $2.6 billion biobucks pact last year, Bristol Myers Squibb is making a second and final cut to its pact with I-O biotech Jounce.

With its $400 million Fund XII, Atlas Venture became the latest VC shop to close a major fund since the WHO officially declared COVID-19 a pandemic.